CHINA APPROVES TWO MORE COVID-19 VACCINES FOR WIDER USE

26/02/2021

Aslıhan DOĞRU -TDO- The Chinese government has given conditional approval to 2 new types of coronavirus (Covid-19) vaccines for wide-ranging use.

Covid-19 vaccines from Chinese private company CanSino Biologics and public company Sinopharm have also been conditionally approved for wide-ranging use, the National Medical Products Administration (NMPA) said in a statement.

Both vaccines are already used among groups of people selected for emergencies, the statement said.

CanSino's vaccine was developed by a team led by Chen Wei, a researcher at the Institute of Medicine within China's Academy of Military Sciences, the statement said.

The vaccine was said to be 65.28% effective.

The vaccine can be stored at 2-8 centigrade degrees and made more accessible, especially in areas where there are not enough public health facilities, the statement said.